Verteporfin-Loaded Mesoporous Silica Nanoparticles’ Topical Applications Inhibit Mouse Melanoma Lymphangiogenesis and Micrometastasis In Vivo
暂无分享,去创建一个
U. Dianzani | M. Invernizzi | L. Marchese | F. Renò | E. Gianotti | I. Miletto | N. Clemente | M. Sabbatini | F. Renó
[1] R. Cavalli,et al. Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape , 2021, Pharmaceutics.
[2] Kehan Chen,et al. Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment , 2021, Nanoscale Research Letters.
[3] A. Eichmann,et al. Lymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases , 2020, Frontiers in Physiology.
[4] Yue Zhang,et al. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro. , 2020, Talanta.
[5] U. Dianzani,et al. Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo. , 2019, Journal of photochemistry and photobiology. B, Biology.
[6] Kshitiz,et al. Systems Biology of Cancer Metastasis. , 2019, Cell systems.
[7] Carola Berking,et al. Melanoma , 2018, The Lancet.
[8] C. Passirani,et al. Nanomedicine as a potent strategy in melanoma tumor microenvironment , 2017, Pharmacological research.
[9] Joan W. Miller,et al. Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity , 2017, Scientific Reports.
[10] L. Marchese,et al. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation. , 2017, Journal of photochemistry and photobiology. B, Biology.
[11] Sabrina Oliveira,et al. Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions , 2017, Cancers.
[12] Tayyaba Hasan,et al. Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy , 2016, Theranostics.
[13] K. Alitalo,et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. , 2016, The Journal of clinical investigation.
[14] J. Gołąb,et al. Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy. , 2016, Photodiagnosis and photodynamic therapy.
[15] M. Chorilli,et al. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review , 2016, Molecules.
[16] L. Marchese,et al. Verteporfin based silica nanoplatform for photodynamic therapy , 2016 .
[17] In-Yong Kim,et al. Toxicity of silica nanoparticles depends on size, dose, and cell type. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[18] F. Tas. Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors , 2012, Journal of oncology.
[19] I. Immonen,et al. Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis , 2011, Science Translational Medicine.
[20] P. V. van Diest,et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. , 2008, Journal of the National Cancer Institute.
[21] G. Cserni. Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure , 2008, Journal of Clinical Pathology.
[22] Michael Detmar,et al. Tumor and lymph node lymphangiogenesis—impact on cancer metastasis , 2006, Journal of leukocyte biology.
[23] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[24] B. Pauli,et al. Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. , 1992, The Journal of clinical investigation.